drugset / Trial / NCT05220228
Prucalopride and Cognition in Recovered Depression
RandomizedParallel-groupTriple-blindOther
Summary
The current study has two aims: 1. To test the effect of 5-HT4 receptor agonism on cognition (including memory, attention and cognitive control) in individuals with previous history of depression. 2. To explore if prucalopride has an effect on emotional processing biases consistent with its effects on serotonin.
Timeline
- Start
- 2022-01-04
- Primary completion
- 2023-11-13
- Completion
- 2023-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prucalopride | Small molecule | 2 mg | — |